Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 63, Issue 3
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Hepatology
Original article
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality
Online download statistics by month:
Online download statistics by month: May 2013 to February 2024
Abstract
Full
Pdf
May 2013
415
50
78
Jun 2013
289
37
51
Jul 2013
129
23
26
Aug 2013
63
13
18
Sep 2013
51
17
24
Oct 2013
59
18
25
Nov 2013
37
11
16
Dec 2013
47
10
15
Jan 2014
40
10
15
Feb 2014
989
40
125
Mar 2014
437
35
71
Apr 2014
267
38
61
May 2014
202
30
39
Jun 2014
85
22
34
Jul 2014
60
26
22
Aug 2014
93
18
23
Sep 2014
52
21
21
Oct 2014
70
26
29
Nov 2014
44
9
20
Dec 2014
48
14
19
Jan 2015
48
11
10
Feb 2015
48
14
13
Mar 2015
57
10
10
Apr 2015
53
11
8
May 2015
19
10
8
Jun 2015
35
4
11
Jul 2015
29
3
5
Aug 2015
18
8
9
Sep 2015
31
8
9
Oct 2015
13
1
4
Nov 2015
18
10
6
Dec 2015
22
3
6
Jan 2016
15
4
10
Feb 2016
21
4
3
Mar 2016
48
7
7
Apr 2016
30
3
10
May 2016
30
15
13
Jun 2016
31
6
6
Jul 2016
41
7
10
Aug 2016
28
5
4
Sep 2016
38
6
7
Oct 2016
37
9
7
Nov 2016
37
8
10
Dec 2016
37
5
7
Jan 2017
46
1
5
Feb 2017
78
2
3
Mar 2017
38
10
5
Apr 2017
40
3
2
May 2017
36
17
18
Jun 2017
40
3
1
Jul 2017
71
4
5
Aug 2017
58
2
3
Sep 2017
54
3
3
Oct 2017
103
3
2
Nov 2017
67
7
6
Dec 2017
111
13
6
Jan 2018
119
7
5
Feb 2018
83
4
1
Mar 2018
44
7
4
Apr 2018
95
5
1
May 2018
83
6
6
Jun 2018
71
3
5
Jul 2018
83
1
2
Aug 2018
32
1
1
Sep 2018
46
1
1
Oct 2018
45
5
3
Nov 2018
49
1
1
Dec 2018
42
4
1
Jan 2019
40
4
4
Feb 2019
32
4
2
Mar 2019
28
0
0
Apr 2019
45
2
0
May 2019
41
4
1
Jun 2019
17
2
4
Jul 2019
18
1
0
Aug 2019
19
5
0
Sep 2019
10
0
0
Oct 2019
49
4
2
Nov 2019
30
3
1
Dec 2019
116
2
10
Jan 2020
22
1
1
Feb 2020
33
1
1
Mar 2020
22
4
2
Apr 2020
23
0
0
May 2020
31
3
2
Jun 2020
21
0
0
Jul 2020
15
1
1
Aug 2020
26
0
0
Sep 2020
64
3
3
Oct 2020
42
1
3
Nov 2020
22
0
0
Dec 2020
23
1
1
Jan 2021
28
2
0
Feb 2021
32
2
1
Mar 2021
28
1
1
Apr 2021
34
2
2
May 2021
12
8
7
Jun 2021
2
2
0
Aug 2021
3
1
1
Sep 2021
6
5
0
Oct 2021
22
2
0
Nov 2021
43
3
1
Dec 2021
57
7
3
Jan 2022
36
2
0
Feb 2022
31
1
0
Mar 2022
43
5
3
Apr 2022
65
3
1
May 2022
54
3
1
Jun 2022
115
5
3
Jul 2022
45
3
1
Aug 2022
79
8
0
Sep 2022
103
3
3
Oct 2022
48
2
0
Nov 2022
44
1
2
Dec 2022
29
0
0
Jan 2023
99
4
1
Feb 2023
24
1
1
Mar 2023
42
5
1
Apr 2023
42
2
0
May 2023
36
3
0
Jun 2023
13
4
1
Jul 2023
26
4
1
Aug 2023
33
3
0
Sep 2023
31
5
1
Oct 2023
39
2
0
Nov 2023
27
7
2
Dec 2023
44
3
2
Jan 2024
25
1
12
Feb 2024
22
2
2
Total
8046
916
1107
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?